Ledger.Open graph →
SEC Form D · Amendment · filed November 19, 2009

Slate Pharmaceuticals, Inc

Offering
$2.8M
Sold
$2.6M
Exemption
—
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

People & firms on this filing (16)

William R. Dahl · Durham, NCDirectorRobert S. Whitehead · Durham, NCExec · DirectorTrygve Mikkelsen · Durham, NCDirectorRichard Deschutter · Durham, NCDirectorKenneth R. Couch · Durham, NCDirectorAnthony Wild · Durham, NCDirectorDouglas Eckert · Durham, NCDirectorMichael Ford · Durham, NCDirectorRichard Brueckner · Jersey City, NJExec · DirectorSean P. Mclaughlin · New York, NYDirectorJohn Cahaly · Boston, MADirectorCollin E. Roche · Chicago, ILDirectorBarry R. Dunn · Chicago, ILDirectorJoseph M. Velli · New York, NYDirectorCharles E. Rappold · New York, NYDirectorChristopher Springer · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗